AU2001234089A1 - Cancer remedy comprising anthranilic acid derivative as active ingredient - Google Patents

Cancer remedy comprising anthranilic acid derivative as active ingredient

Info

Publication number
AU2001234089A1
AU2001234089A1 AU2001234089A AU2001234089A AU2001234089A1 AU 2001234089 A1 AU2001234089 A1 AU 2001234089A1 AU 2001234089 A AU2001234089 A AU 2001234089A AU 2001234089 A AU2001234089 A AU 2001234089A AU 2001234089 A1 AU2001234089 A1 AU 2001234089A1
Authority
AU
Australia
Prior art keywords
active ingredient
acid derivative
anthranilic acid
cancer remedy
remedy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2001234089A
Other versions
AU2001234089B2 (en
Inventor
Takashi Kawamura
Takumi Takeyasu
Naoki Tsuchiya
Takashi Tsuruo
Takao Yamori
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teijin Ltd
Original Assignee
Teijin Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teijin Ltd filed Critical Teijin Ltd
Priority claimed from PCT/JP2001/001090 external-priority patent/WO2001060354A1/en
Publication of AU2001234089A1 publication Critical patent/AU2001234089A1/en
Application granted granted Critical
Publication of AU2001234089B2 publication Critical patent/AU2001234089B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

AU2001234089A 2000-02-15 2001-02-15 Cancer remedy comprising anthranilic acid derivative as active ingredient Ceased AU2001234089B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000-36386 2000-02-15
JP2000036386 2000-02-15
PCT/JP2001/001090 WO2001060354A1 (en) 2000-02-15 2001-02-15 Cancer remedy comprising anthranilic acid derivative as active ingredient

Publications (2)

Publication Number Publication Date
AU2001234089A1 true AU2001234089A1 (en) 2001-11-08
AU2001234089B2 AU2001234089B2 (en) 2005-08-11

Family

ID=18560433

Family Applications (2)

Application Number Title Priority Date Filing Date
AU3408901A Pending AU3408901A (en) 2000-02-15 2001-02-15 Cancer remedy comprising anthranilic acid derivative as active ingredient
AU2001234089A Ceased AU2001234089B2 (en) 2000-02-15 2001-02-15 Cancer remedy comprising anthranilic acid derivative as active ingredient

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AU3408901A Pending AU3408901A (en) 2000-02-15 2001-02-15 Cancer remedy comprising anthranilic acid derivative as active ingredient

Country Status (5)

Country Link
US (2) US20030220402A1 (en)
EP (1) EP1256341A4 (en)
AU (2) AU3408901A (en)
CA (1) CA2400264A1 (en)
WO (1) WO2001060354A1 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6897220B2 (en) 2001-09-14 2005-05-24 Methylgene, Inc. Inhibitors of histone deacetylase
AU2002327627B2 (en) * 2001-09-14 2006-09-14 Methylgene Inc. Inhibitors of histone deacetylase
US7868204B2 (en) 2001-09-14 2011-01-11 Methylgene Inc. Inhibitors of histone deacetylase
GB0319124D0 (en) * 2003-08-14 2003-09-17 Smithkline Beecham Corp Chemical compounds
WO2005030705A1 (en) 2003-09-24 2005-04-07 Methylgene, Inc. Inhibitors of histone deacetylase
KR100557093B1 (en) * 2003-10-07 2006-03-03 한미약품 주식회사 Tetrazole derivatives having inhibitory activity against multi-drug resistance and preparation thereof
CA2559733C (en) * 2004-03-26 2014-05-13 Methylgene Inc. Inhibitors of histone deacetylase
US7253204B2 (en) 2004-03-26 2007-08-07 Methylgene Inc. Inhibitors of histone deacetylase
MX2007001215A (en) 2004-08-06 2007-04-17 Otsuka Pharma Co Ltd Aromatic compounds.
BRPI0611784A2 (en) 2005-06-14 2010-09-28 Hoffmann La Roche compounds, process for their manufacture, pharmaceutical compositions comprising them and use of such compounds
US8053454B2 (en) * 2005-10-06 2011-11-08 Exelixis, Inc. Pyridopyrimidinone inhibitors of PIM-1 and/or PIM-3
PT1957073E (en) 2005-12-05 2014-05-12 Otsuka Pharma Co Ltd Medicinal drug
US8598168B2 (en) 2006-04-07 2013-12-03 Methylgene Inc. Inhibitors of histone deacetylase
UA95978C2 (en) 2006-10-02 2011-09-26 Оцука Фармас'Ютікел Ко., Лтд. Stat3/5 activation inhibitor
GB0725214D0 (en) * 2007-12-24 2008-02-06 Karobio Ab Pharmaceutical compounds
ES2909884T3 (en) * 2013-08-20 2022-05-10 Univ Washington Through Its Center For Commercialization Novel and Specific Inhibitors of Cytochrome P450 Retinoic Acid Hydroxylase 26
CN113811300A (en) * 2019-03-15 2021-12-17 总医院公司 Novel small molecule inhibitors of TEAD transcription factor

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2934543A1 (en) * 1979-08-27 1981-04-02 Basf Ag, 6700 Ludwigshafen SUBSTITUTED N-BENZOYLANTHRANILE ACID DERIVATIVES AND THEIR ANYDRO COMPOUNDS, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS HERBICIDES
US5705521A (en) * 1990-02-12 1998-01-06 The Center For Innovative Technology Use of allosteric hemoglobin modifiers in combination with radiation therapy to treat carcinogenic tumors
GB9022785D0 (en) * 1990-10-19 1990-12-05 Merck Sharp & Dohme Therapeutic agents
JPH05301838A (en) * 1991-10-15 1993-11-16 Mitsubishi Kasei Corp Styrene derivative
CN1048239C (en) * 1994-05-31 2000-01-12 帝人株式会社 Naphthalene deriv.
US5808144A (en) * 1995-11-27 1998-09-15 Teijin Limited Benzene derivatives
KR100682276B1 (en) * 1998-07-24 2007-02-28 데이진 가부시키가이샤 Anthranilic acid derivatives

Similar Documents

Publication Publication Date Title
AU781269C (en) Pharmaceutical compositions
AU2001269529A1 (en) Medicine comprising dicyanopyridine derivative
HUP0501186A2 (en) Pharmaceutical compositions comprising active vitamin d compounds
IL160253A0 (en) Carboxylic acid derivative compounds and drugs comprising these compounds as the active ingredient
AU2001234089A1 (en) Cancer remedy comprising anthranilic acid derivative as active ingredient
AU2001250420A1 (en) Pharmaceutical compositions
AU2001274307A1 (en) Pharmaceutical compositions
AU2002342968A1 (en) Fatty acid compounds, preparation and uses thereof
AU3408901A (en) Cancer remedy comprising anthranilic acid derivative as active ingredient
AU2002257582A1 (en) Pharmaceutical formulation
AU2001289102A1 (en) Topical formulations for delivery of interleukin-11
AU2001280167A1 (en) Novel propenohydroxamic acid derivatives
AU2001283344A1 (en) Dermatological formulation
AU2001244671A1 (en) Quinolonecarboxylic acid derivative
AU2001273919A1 (en) Pharmaceutical compositions
AUPQ365299A0 (en) Anthranilic acid derivatives
AU2002350942A1 (en) Imidazolidineacetic acid derivatives
AU2002315848A1 (en) Remedies for eosinophilic diseases
AU2001248943A1 (en) Pharmaceutical curative compound
AU2001260089A1 (en) Pharmaceutical compositions comprising desglymidodrine as an active drug substance
AUPQ851000A0 (en) Rapid fatty acid delivery
AU2001274231A1 (en) Novel aqueous anti-inflammatory pharmaceutical formulation
AU2001264129A1 (en) Novel aqueous anti-inflammatory pharmaceutical formulation
AU2002363776A1 (en) Carboxylic acid derivative compounds and drugs containing the same as the active ingredient
AU2002315287A1 (en) Pharmaceutical composition comprising clavulanic acid